Tuberculosis PNLE Questions

Introduction

The live Tangerine inventory contains 21 original PNLE-style practice questions on Tuberculosis, last updated August 12, 2026. Use them as diagnostic practice for recognition, testing, treatment, adherence, prevention, contacts, and public-health action.

This NP3: Community Health topic trains you to connect a TB cue to a safe nursing decision: distinguish screening from evaluation of possible disease, support the diagnostic workup, apply TB-specific precautions, prepare and monitor treatment, address adherence, identify contacts, and escalate public-health needs. It also requires attention to drug-susceptibility testing when response is concerning and to clinical situations that may require hospitalization.

The topic is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS. Under the 2025 Enhanced TOS, it is not a separate official test subject, and no microtopic weight can be assigned to Tuberculosis. Exact topic distribution varies by exam form, so use the inventory to build decision skills rather than to predict a question count.

Key concepts

Separate screening from evaluation of possible disease
Recognize: A TB screening context addresses infection or risk, while a person with concerning symptoms or findings needs the prescribed evaluation for possible active disease.
Decide: Match the test, urgency, specimen process, and referral plan to the clinical question.
Avoid: Treating a screening result as a complete diagnosis or dismissing disease because the encounter began as screening.
Identify the TB organism and diagnostic pathway
Recognize: Pulmonary tuberculosis is associated with Mycobacterium tuberculosis. Diagnosis depends on the ordered clinical, imaging, and microbiologic assessment rather than on one isolated cue.
Decide: Protect the patient and staff while obtaining the correct specimen and following the laboratory and referral instructions.
Avoid: Guessing the organism from a generic infection pattern or delaying action while waiting for an unrelated test.
Verify the precondition for treatment
Recognize: TB therapy is regimen-based and must fit the disease presentation, site, and available susceptibility information.
Decide: Confirm the diagnostic information, baseline assessment needs, medication history, interaction risks, contraindications, and ability to follow the plan before initiation.
Avoid: Starting an incomplete regimen, changing prescribed drugs independently, or treating readiness as mere possession of medication.
Make adherence a clinical intervention
Recognize: Adherence can be affected by side effects, stigma, transportation, cost, competing responsibilities, and misunderstanding of the treatment plan.
Decide: Use clear teaching, an agreed follow-up plan, barrier assessment, and the program's prescribed adherence-support strategy.
Avoid: Assuming that a patient who agrees verbally will complete therapy or that fewer tablets automatically means reliable adherence.
Respond appropriately to nonresponse
Recognize: Persistent symptoms, concerning clinical progress, missed doses, or other unexpected findings require reassessment rather than an automatic label of treatment failure.
Decide: Escalate for review of adherence, the diagnosis, the regimen, and drug-susceptibility testing when indicated by the clinical plan.
Avoid: Adding, stopping, or substituting TB drugs without the responsible prescriber's and program's direction.
Protect contacts and support public-health action
Recognize: Close or prolonged exposure to a person with potentially infectious pulmonary TB raises the need for contact assessment, especially when a contact may be medically vulnerable.
Decide: Identify and refer contacts through the appropriate public-health process, provide understandable instructions, and support required reporting and follow-up.
Avoid: Waiting for every contact to develop symptoms or treating contact tracing as optional education.
Plan safe transport and determine need for hospitalization
Recognize: A patient with possible or confirmed pulmonary TB may need TB-specific respiratory precautions during movement, while severity, complications, monitoring needs, and ability to receive safe care determine hospitalization decisions.
Decide: Coordinate precautions before transport, notify the receiving team, and escalate unstable or unsafe outpatient situations.
Avoid: Using routine transport procedures or assuming every TB patient has the same site, severity, treatment duration, or level of care.

What to expect on the PNLE

The inventory supports several forms of nursing judgment: confirming a diagnostic pathway, selecting an initial treatment action, recognizing a high-risk exposure, planning transport precautions, identifying the organism, checking treatment preconditions, responding to nonresponse with drug-susceptibility testing, and deciding when escalation or hospitalization assessment is needed. Exact topic distribution varies by exam form, so these forms describe the practice scope rather than a promised exam pattern.

Its live difficulty distribution is 12 easy, 6 medium, and 3 hard questions. The Bloom distribution is 8 remembering, 8 applying, 2 analyzing, and 3 evaluating, which supports a study plan that moves from accurate recall of TB concepts to safe action selection and comparison of competing priorities.

Remembering: retrieve the organism, core TB terms, and the purpose of common diagnostic or treatment steps.
Applying: use a symptom, exposure, treatment, or transport cue to select the next safe nursing action.
Analyzing: connect nonresponse, adherence concerns, susceptibility testing, disease site, and public-health implications.
Evaluating: prioritize hospitalization, treatment readiness, contact action, or escalation when several options appear reasonable.

Study tips

Begin with diagnostic practice. Answer the 21 inventory questions without looking at rationales. For each item, record the cue you used, your selected action, and your confidence so you can separate knowledge gaps from misreading or prioritization errors.
Use focused retrieval for weak decisions. Build a one-page TB decision diagram: TB symptom or exposure cue → screening versus active-disease evaluation → specimen and safety plan → treatment readiness → adherence and follow-up → contact or public-health action. Add a two-column comparison for screening questions and active-disease evaluation questions.
Review every rationale and error. For each missed or low-confidence item, write one sentence explaining why the best option is safer. Label the error as recognition, testing, treatment readiness, adherence, contact action, transport, or escalation, then verify that your correction fits the stem's specific cue.
Retry with spaced retrieval. Return to missed items and your decision diagram during later study sessions. Cover the answer and retrieve the next action first, then explain what finding would change the plan, such as nonresponse, a vulnerable contact, or clinical instability.
Finish with mixed timed practice. Mix Tuberculosis with its adjacent practice topics, Communicable Disease Basics and Disease Control Laws, after focused review. Keep the timer secondary to safe prioritization, then review whether you selected an action that protects the patient, contacts, staff, and continuity of care.

Common mistakes to avoid

Calling a screening result the final diagnosis. The correcting cue is the purpose of the test. A screening result should lead to the appropriate evaluation when active disease is possible, not to premature reassurance or treatment decisions without the prescribed workup.
Choosing a test without identifying the clinical question. The safety principle is to distinguish infection screening from evaluation of suspected disease and to follow the ordered specimen pathway. Convenience, familiarity, or a single symptom should not determine the entire diagnostic plan.
Starting therapy before treatment readiness is established. Check the precondition in the stem: diagnostic information, baseline assessment needs, medication risks, interactions, and the patient's ability to follow the regimen. A medication order alone does not remove the need for preparation.
Ignoring nonresponse or changing drugs independently. Persistent symptoms or unexpected progress is a cue to reassess adherence, diagnosis, regimen, and the need for drug-susceptibility testing. The nurse escalates and coordinates rather than improvising a new regimen.
Assuming fixed-dose combinations solve adherence. They may simplify administration, but the patient still needs correct, sustained use of the prescribed regimen and follow-up. Assess barriers and understanding instead of equating fewer tablets with completion.
Using routine transport or overlooking contacts. Possible or confirmed pulmonary TB calls for advance coordination of TB-specific precautions, while close contacts require public-health assessment. The correcting principle is prevention of further exposure through timely action, not waiting for symptoms or handling transport as routine.

Try a question

A real Tuberculosis question from our bank. Give it a shot.

Medium

A nurse in a Philippine hospital is caring for a patient suspected of having tuberculosis and has placed the patient under airborne precautions. Which diagnostic test is most definitive for confirming active TB?

A

Sputum culture growing Mycobacterium tuberculosis.

B

Chest X-ray showing lung abnormalities.

C

Presence of blood in the sputum.

D

Positive result on a tuberculin skin test.

Rationale

A sputum culture that grows Mycobacterium tuberculosis is the most definitive diagnostic test for confirming active tuberculosis (TB). This test directly detects the presence of the causative organism, which provides absolute confirmation of active infection. Identification of Mycobacterium tuberculosis from a patient's sputum confirms active TB and guides treatment and infection-control decisions.

Option	Analysis
A. Sputum culture growing Mycobacterium tuberculosis.	Correct. This is the gold standard for TB diagnosis because it provides direct evidence of the bacteria causing the disease. Sputum culture not only confirms the diagnosis but also allows for drug susceptibility testing, which is essential for tailoring therapy and addressing potential drug resistance. However, it may take several weeks due to the slow-growing nature of MTB, but its specificity is unrivaled.
B. Chest X-ray showing lung abnormalities.	Incorrect. While chest X-ray can reveal patterns suggestive of TB (e.g., upper lobe infiltrates, cavities), these findings are not specific to tuberculosis and can be seen in other lung conditions (e.g., pneumonia, malignancies). X-rays are used for screening or assessing disease extent, but cannot confirm active TB on their own.
C. Presence of blood in sputum.	Incorrect. Hemoptysis (coughing up blood) may occur in advanced or cavitary TB but can also be caused by many other lung diseases such as bronchitis, lung cancer, or pulmonary embolism. It is a symptom, not a diagnostic indicator, and lacks specificity for TB.
D. Positive result on a tuberculin skin test.	Incorrect. The tuberculin skin test (TST) detects immune sensitization to TB (latent infection) but does not distinguish between active and latent TB. A positive TST may occur in individuals with prior BCG vaccination or exposure to non-TB mycobacteria, so it is not diagnostic of active disease.

Clinical Concepts

Pulmonary TB can spread through airborne particles, so suspected infectious cases require prompt identification and appropriate airborne precautions.
Definitive diagnosis affects not only the patient's treatment but also public health interventions such as contact tracing and community notification.

Clinical Pearl: Remember 'C for Culture, C for Confirm'—only sputum culture confirms active TB by demonstrating the actual organism. All other tests are suggestive, not definitive.

Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 13, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.